{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:00:08Z","timestamp":1790503208926,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National natural science foundation of China","doi-asserted-by":"crossref","award":["81460398"],"award-info":[{"award-number":["81460398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National natural science foundation of China","doi-asserted-by":"crossref","award":["81860457"],"award-info":[{"award-number":["81860457"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Guangxi Province, China","award":["2017GXNSFAA198106"],"award-info":[{"award-number":["2017GXNSFAA198106"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejogrb.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T12:37:29Z","timestamp":1538656649000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Diagnostic value of HE4 in ovarian cancer: A meta-analysis"],"prefix":"10.1016","volume":"231","author":[{"given":"Jinbing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2018.10.008_bib0010","series-title":"N H. SEER Cancer statistics review, 1975-2014","year":"2017"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.10.008_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cncr.22371","article-title":"Development of an ovarian cancer symptom index: possibilities for earlier detection","volume":"109","author":"Goff","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.10.008_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary","volume":"108","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2018.10.008_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.6004\/jnccn.2011.0008","article-title":"Epithelial ovarian cancer","author":"Morgan","year":"2011","journal-title":"JNCCN\u2013J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.ejogrb.2018.10.008_bib0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","article-title":"Use of a symptom index, CA125, and HE4 to predict ovarian cancer","volume":"116","author":"Andersen","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ejogrb.2018.10.008_bib0035","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2018.10.008_bib0040","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s13277-014-1811-6","article-title":"Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2018.10.008_bib0045","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2015.06.021","article-title":"A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - an international multicenter study in women with an ovarian mass","volume":"138","author":"Karlsen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2018.10.008_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-8-11","article-title":"Abdel Ghaffar HM. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response","volume":"8","author":"Hamed","year":"2013","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.ejogrb.2018.10.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068994","article-title":"Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma","volume":"8","author":"Zhuang","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejogrb.2018.10.008_bib0060","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2012.10.036","article-title":"Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis","volume":"167","author":"Lin","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.ejogrb.2018.10.008_bib0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7414","key":"10.1016\/j.ejogrb.2018.10.008_bib0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"10","key":"10.1016\/j.ejogrb.2018.10.008_bib0080","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2018.10.008_bib0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2288-9-73","article-title":"Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds","volume":"9","author":"Hamza","year":"2009","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ije\/31.1.88","article-title":"Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy","volume":"31","author":"Song","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.10.008_bib0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2018.10.008_bib0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcla.20340","article-title":"The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass","volume":"23","author":"Montagnana","year":"2009","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0105","first-page":"111","article-title":"HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses","volume":"11","author":"Abdel-Azeez","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.ejogrb.2018.10.008_bib0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajog.2011.05.017","article-title":"Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women","volume":"205","author":"Holcomb","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2018.10.008_bib0115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IGC.0b013e31821a3726","article-title":"Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma","volume":"21","author":"Chang","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2018.10.008_bib0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2018.10.008_bib0125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.10.008_bib0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2018.10.008_bib0135","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Munoz","year":"2014","journal-title":"Tumor Biol"},{"issue":"5","key":"10.1016\/j.ejogrb.2018.10.008_bib0140","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.7314\/APJCP.2014.15.5.1949","article-title":"Modification of cutoff values for HE4, CA125, the risk of malignancy index, and the risk of malignancy algorithm for ovarian cancer detection in Jakarta, Indonesia","volume":"15","author":"Winarto","year":"2014","journal-title":"Asian Pac J Cancer Prev : APJCP"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0145","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12032-013-0808-0","article-title":"HE4 combined with CA125: favorable screening tool for ovarian cancer","volume":"31","author":"Ghasemi","year":"2014","journal-title":"Med Oncol (Northwood, London, England)"},{"issue":"9","key":"10.1016\/j.ejogrb.2018.10.008_bib0150","first-page":"991","article-title":"Comparison of HE4, CA125, and risk of ovarian malignancy algorithm (ROMA) in the prediction of ovarian cancer in Korean women","volume":"25","author":"Cho","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2018.10.008_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.11.013","article-title":"Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses","volume":"440","author":"Chen","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.10.008_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/br.2016.682","article-title":"The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer","volume":"5","author":"Wei","year":"2016","journal-title":"Biomed Rep"},{"issue":"1-2","key":"10.1016\/j.ejogrb.2018.10.008_bib0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clinbiochem.2015.07.029","article-title":"Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China","volume":"49","author":"Xu","year":"2016","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.ejogrb.2018.10.008_bib0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/med-2016-0024","article-title":"The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer","volume":"11","author":"Zheng","year":"2016","journal-title":"Open Med (Warsaw, Poland)"},{"issue":"12","key":"10.1016\/j.ejogrb.2018.10.008_bib0180","first-page":"1263","article-title":"Diagnostic accuracy and optimal cutoff value of serum HE4 to predict ovarian cancer in Thai women with pelvic masses","volume":"99","author":"Yanaranop","year":"2016","journal-title":"J Med Assoc Thai"},{"issue":"7305","key":"10.1016\/j.ejogrb.2018.10.008_bib0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.10.008_bib0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.juro.2008.04.026","article-title":"How to use an article about a diagnostic test","volume":"180","author":"Scales","year":"2008","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.ejogrb.2018.10.008_bib0195","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users\u2019 guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejogrb.2018.10.008_bib0200","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2018.10.008_bib0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/labmed\/lmx036","article-title":"Human epididymis protein 4 as a potential biomarker of chronic kidney disease in female patients with normal ovarian function","volume":"48","author":"Yuan","year":"2017","journal-title":"Lab Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518310169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518310169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:42:30Z","timestamp":1759556550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211518310169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":41,"alternative-id":["S0301211518310169"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.10.008","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of HE4 in ovarian cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}